UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
AP reveals new developments in autoimmune disease medicine through extraordinary patient experiences
Told through people who have had their memories, sanity and childhoods stolen by autoimmune disease, the AP reveals and explains exciting new developments ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...
Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
Is Health Canada's Approval of VYVGART SC Transforming the Investment Case for argenx (ENXTBR:ARGX)?
On November 5, 2025, argenx SE announced that Health Canada approved VYVGART SC (efgartigimod alfa injection) as a monotherapy for adults with active chronic inflammatory demyelinating polyneuropathy ...
HK Innoen is accelerating the expansion of its portfolio in geriatric and metabolic diseases by launching full-scale development of a treatment for ...
CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada ...
The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases – by reprogramming patients’ out-of-whack immune ...
Autoimmune diseases can affect just about every part of the body – and tens of millions of people Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But ...
NEW YORK, Nov 5 (Reuters) - The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, was no more effective than a placebo, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results